» Articles » PMID: 26413818

DNA Methylation Dynamics During Differentiation, Proliferation, and Tumorigenesis in the Intestinal Tract

Overview
Journal Stem Cells Dev
Date 2015 Sep 29
PMID 26413818
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

DNA methylation, an epigenetic control mechanism in mammals, is widely present in the intestinal tract during the differentiation and proliferation of epithelial cells. Cells in stem cell pools or villi have different patterns of DNA methylation. The process of DNA methylation is dynamic and occurs at many relevant regulatory elements during the rapid transition of stem cells into fully mature, differentiated epithelial cells. Changes in DNA methylation patterns most often take place in enhancer and promoter regions and are associated with transcription factor binding. During differentiation, enhancer regions associated with genes important to enterocyte differentiation are demethylated, activating gene expression. Abnormal patterns of DNA methylation during differentiation and proliferation in the intestinal tract can lead to the formation of aberrant crypt foci and destroy the barrier and absorptive functions of the intestinal epithelium. Accumulation of these epigenetic changes may even result in tumorigenesis. In the current review, we discuss recent findings on the association between DNA methylation and cell differentiation and proliferation in the small intestine and highlight the possible links between dysregulation of this process and tumorigenesis.

Citing Articles

Methionine deficiency and its hydroxy analogue influence chicken intestinal 3-dimensional organoid development.

Wang Y, Hou Q, Wu Y, Xu Y, Liu Y, Chen J Anim Nutr. 2022; 8(1):38-51.

PMID: 34977374 PMC: 8669257. DOI: 10.1016/j.aninu.2021.06.001.


Leptin Receptor Overlapping Transcript (LEPROT) Is Associated with the Tumor Microenvironment and a Prognostic Predictor in Pan-Cancer.

Li B, He Y, Li P, Chen X Front Genet. 2021; 12:749435.

PMID: 34804118 PMC: 8596502. DOI: 10.3389/fgene.2021.749435.


Hypermethylation of as a Novel Tumor Suppressor Involved in Tumor Growth and Prognosis in Gastric Cancer.

Sumei S, Xiangyun K, Fenrong C, Xueguang S, Sijun H, Bin B Front Cell Dev Biol. 2021; 9:624871.

PMID: 33553182 PMC: 7859350. DOI: 10.3389/fcell.2021.624871.


subspecies engineered to produce mycosporin-like amino acids in colorectal cancer prevention.

Bozkurt H, Quigley E, Kara B SAGE Open Med. 2019; 7:2050312119825784.

PMID: 30719295 PMC: 6348500. DOI: 10.1177/2050312119825784.


Genes controlling the activation of natural killer lymphocytes are epigenetically remodeled in intestinal cells from germ-free mice.

Poupeau A, Garde C, Sulek K, Citirikkaya K, Treebak J, Arumugam M FASEB J. 2018; 33(2):2719-2731.

PMID: 30303739 PMC: 6338647. DOI: 10.1096/fj.201800787R.


References
1.
Sheaffer K, Kaestner K . Transcriptional networks in liver and intestinal development. Cold Spring Harb Perspect Biol. 2012; 4(9):a008284. PMC: 3428765. DOI: 10.1101/cshperspect.a008284. View

2.
Eden A, Gaudet F, Waghmare A, Jaenisch R . Chromosomal instability and tumors promoted by DNA hypomethylation. Science. 2003; 300(5618):455. DOI: 10.1126/science.1083557. View

3.
Wright N . Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer. Int J Exp Pathol. 2000; 81(2):117-43. PMC: 2517719. DOI: 10.1046/j.1365-2613.2000.00146.x. View

4.
Giles R, van Es J, Clevers H . Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 2003; 1653(1):1-24. DOI: 10.1016/s0304-419x(03)00005-2. View

5.
Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A . Sp1 elements protect a CpG island from de novo methylation. Nature. 1994; 371(6496):435-8. DOI: 10.1038/371435a0. View